# Beijing Tsinghua Chang Gung Hospital: Observational study in Chronic Heart Failure (918 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Beijing Tsinghua Chang Gung Hospital |
| Sponsor type | Academic and hospital |
| Study | Vericiguat Use and Incident Atrial Fibrillation in Chronic Heart Failure |
| NCT ID | NCT07877831 |
| Phase | Observational |
| Status | active not recruiting |
| Conditions | Chronic Heart Failure |
| Intervention types | drug |
| Target enrollment | 918 |
| Site countries | China |
| Posted | 2026-10-16 |
| Planned start | 2023-11-01 |
| Event | Newly registered study |
| Event date | 2026-10-16 |

## Why this score
- 918 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07877831). Last refreshed: 2026-11-05T08:46:16.625Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.